Thermo Fisher Scientific Inc. (TMO)

AI-powered earnings prediction for Thermo Fisher Scientific Inc. (TMO).

510.93
-0.81%
USD, 2 days ago
Market Cap
191.56B
Google

Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Sector
Healthcare
Industry
Diagnostics & Research
Phone
781 622 1000
Headquarters
168 Third Avenue
Waltham, MA, 02451
United States

Key Metrics

P/E Ratio (TTM)
28.77
Forward P/E
18.92
Price to Book
3.59
Beta
0.95
Profit Margin
15.05%
Gross Margin
41.68%
Return on Equity
13.02%
Return on Assets
5.04%
Earnings Growth
9.00%
Revenue Growth
7.20%
Dividend Yield
33.00%
Dividend Rate
$1.72

Financial Health

Total Cash
$10.10B
Total Debt
$39.39B
Debt to Equity
73.57
Current Ratio
1.89
Free Cash Flow
$4.36B
Operating Cash Flow
$7.82B

Analyst Recommendations

Target Price (Mean)
$666.46
Target High
$750.00
Target Low
$595.00
Recommendation
buy
Analyst Coverage
24 Analysts

Trading Ideas

Related Stocks